Dr. Jules A. Cohen, MD

Dr. Cohen practices at Stony Brook Internists in Stony Brook, New York.

Dr. Cohen's NPI, 1215112289, was assigned on January 8, 2008. Dr. Cohen graduated from Weill Cornell Medicine in 2001. Dr. Cohen holds New York license 227041.

Dr. Cohen's primary practice is Stony Brook Internists, at 3 Edmund D Pellegrino Rd, Stony Brook, NY 11794. The practice phone is (631) 444-2448.

Dr. Cohen's primary practice is Stony Brook Internists in Stony Brook, New York. Dr. Cohen is also affiliated with Stony Brook University Hospital. The medical group on file is Stony Brook Internists. Dmand AI also links Dr. Cohen to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cohen practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cohen's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cohen is board certified in hematology by the American Board of Internal Medicine. Dr. Cohen is licensed in New York.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and purpura and thrombocytopenia among the conditions Dr. Cohen treats.

CMS data shows 719 Medicare services from Dr. Cohen across 9 procedure codes in 2024, for 310 Medicare patients. Medicare paid $73,763 for them.

CMS counts 310 Medicare patients who saw Dr. Cohen in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have cancer, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cohen's median patient age at 66, with 92% women.

In 2024, Dr. Cohen wrote 1,016 Medicare Part D claims for 206 patients. 90% of them were for generic drugs. CMS names the drug for 771 of them, across 21 drugs with 11 or more claims each, at $64,590 in total drug cost. In 2023, CMS named 866 claims across 21 drugs.

Dr. Cohen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 32 papers to Dr. Cohen, published from 2011 to 2025. 2015 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Erythrocytes and Hemoglobins. Dr. Cohen has published most often in Am J Med. Dr. Cohen's most frequent co-authors are Marshall Albert Lichtman, MD, Lea N. Baer, MD and Lev Y. Bangiyev, DO.

Dmand AI links Dr. Cohen to 6 clinical trials, 4 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating and Neoplasm, Residual. ECOG-ACRIN Cancer Research Group sponsors the most, 2.

CMS Open Payments shows 492 general payments to Dr. Cohen from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Novartis Pharmaceuticals Corporation paid the most, $262,991.

Dr. Cohen graduated from Weill Cornell Medicine in 2001.

Dr. Cohen is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.